Recall: D-0333-2026
Class II - Potentially Harmful
Class IIClassification
2026-02-05Initiated
OngoingStatus
Fresenius Kabi Compounding, LLFirm
Product
acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
Reason
Lack of Assurance of Sterility
Distribution
US Nationwide.
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.